Home›Stock Screener›Sanjivani Paranteral›Quarterly Results

Sanjivani Paranteral Quarterly Results

Latest Quarter Net Profit
₹1 Cr
QMar 2026
Quarterly Results

Sanjivani Paranteral quarterly results. In Mar 2026, Sanjivani Paranteral (SANJIVIN) reported revenue ₹14 Cr and net profit ₹1 Cr — revenue -26.3% YoY. For annual financials, live price and key ratios, visit SANJIVIN screener.

SANJIVIN Quarterly Results — Revenue, Profit & EPS Highlights

Sanjivani Paranteral latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Check SANJIVIN market value to track the company's total market size over time.

  • Revenue of ₹14 Cr in Mar 2026 (-41.7% vs Jun 2026, -26.3% vs Mar 2025)
  • Net Profit of ₹1 Cr in Mar 2026 (-66.7% vs Jun 2026, -50.0% vs Mar 2025)
  • EBITDA of ₹2 Cr in Mar 2026 (-50.0% vs Jun 2026)
  • Operating Margin of 12.0% in Mar 2026 (-5.0pp vs Jun 2026)
  • Earnings Per Share of ₹0.49 in Mar 2026 (-75.9% vs Jun 2026)

Sanjivani Paranteral Quarterly Results — Revenue, EBITDA, Net Profit & EPS

SANJIVIN quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Mar 2026 Jun 2026 Sept 2025 Mar 2025 Jun 2025 QoQ YoY
Revenue (₹ Cr) 14 24 16 19 18 -41.7% -26.3%
Net Profit (₹ Cr) 1 3 2 2 2 - -
EBITDA (₹ Cr) 2 4 2 3 3 - -
EPS (₹) 0.49 2.03 1.33 1.84 1.46 - -
Operating Margin (%) 12.0% 17.0% 15.0% 14.0% 15.0% - -

SANJIVIN Share Price Trend — 1-Year Movement Across Quarterly Results

Sanjivani Paranteral 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Review SANJIVIN price earnings ratio to evaluate earnings-based valuation against sector peers.

Profitability Ratios

Profit Margin 7.1%
EBITDA Margin 14.3%
Operating Margin 12.0%
ROE (Annual) 7.8%

Balance Sheet Highlights

Total Assets ₹88 Cr
Total Equity ₹51 Cr
Current Assets ₹36 Cr
Current Liabilities ₹11 Cr

Cash Flow Analysis

Operating Cash Flow ₹0 Cr
Investing Cash Flow ₹-10 Cr
Financing Cash Flow ₹10 Cr
Net Cash Flow ₹0 Cr

Current Market Data

Current Price ₹175.05
Exchange BSE
Last Updated Oct 06, 2026

Revenue Trend (₹ Cr)

Mar 2025 19
Sept 2025 16
Jun 2026 24
Mar 2026 14

Net Profit Trend (₹ Cr)

Mar 2025 2
Sept 2025 2
Jun 2026 3
Mar 2026 1

Operating Margin Trend (%)

Mar 2025 14.0%
Sept 2025 15.0%
Jun 2026 17.0%
Mar 2026 12.0%

SANJIVIN vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Sanjivani Paranteral latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Mar 2026 		₹432,120.23 Cr 1804.1 15,018 2,710 -5.6% - 18.0% 159.7
Divis Laboratories
Mar 2026 		₹244,124.91 Cr 9550.0 2,986 751 -5.0% - 25.2% 337.3
Torrent Pharmaceuti…
Mar 2026 		₹188,719.51 Cr 4772.0 4,111 364 +27.7% +42.2% 8.9% 414.6
Zydus Life Science
Mar 2026 		₹113,615.69 Cr 1159.5 7,569 1,341 -4.3% - 17.7% 91.7
Laurus Labs
Mar 2026 		₹109,629.35 Cr 2050.0 1,823 282 -10.5% - 15.5% 396.5
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data

QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores